KLK3 and posterior cortical atrophy: Radical prostatectomy (RP) serves as the primary treatment for clinically localized PCa; however, approximately 20–40% of patients develop biochemical recurrence (BCR), characterized by two consecutive prostate-specific antigen (PSA) elevations above 0.2 ng/mL following surgery [2,3,4].